Treatment Prioritisation and Cost-Effectiveness Analysis for HBV Cure - Real-World Evidence from a Territory-Wide Cohort

NCT06627608 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
10000
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Chinese University of Hong Kong